In contrast to the prior study, which enrolled obese individuals regardless of glycemic status, our analysis was limited to patients with confirmed T2DM, allowing for a more targeted assessment within the population for whom GLP-1 RA are primarily indicated. The gene discussed is GCG; the disease is type 2 diabetes mellitus.